NCT04137939 The Effect of IoT-based Smart Exercises System in the Senior Adults
| NCT ID | NCT04137939 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cheng-Kung University Hospital |
| Condition | Elderly Exercise |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2019-07-15 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2019-07-15 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Subjects are divided into two groups, (1) Control (Ctrl) and (2) Smart Exercise (SE) group. Ctrl group are instructed to maintain their daily life. SE participants are instructed to do exercise with smart exercise system twice per week for 12 weeks. The physical fitness tests and questionnaire of both group are performed before and after the 12-week exercise program.
Eligibility Criteria
Inclusion Criteria: * Adult over 50 years old * No significant limb disability or joint deformation * No history of cardiovascular disease * Never lost balance due to dizziness in the past 12 months Exclusion Criteria: * limb disability or joint deformation * history of cardiovascular disease * lost balance due to dizziness in the past 12 months * cognitive deficits
Contact & Investigator
Li-Chieh Kuo, Ph. D.
STUDY DIRECTOR
National Cheng-Kung University Hospital
Frequently Asked Questions
Who can join the NCT04137939 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Elderly Exercise. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04137939 currently recruiting?
Yes, NCT04137939 is actively recruiting participants. Contact the research team at jkkuo@mail.ncku.edu.tw for enrollment information.
Where is the NCT04137939 trial being conducted?
This trial is being conducted at Tainan, Taiwan.
Who is sponsoring the NCT04137939 clinical trial?
NCT04137939 is sponsored by National Cheng-Kung University Hospital. The principal investigator is Li-Chieh Kuo, Ph. D. at National Cheng-Kung University Hospital. The trial plans to enroll 400 participants.